Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7352 p676
4 June 2005

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Medication review
· Clinical trials
· The Council
· Annual general meeting
· Pharmacology
· General election
· Technicians
· Ischaemic events
· Complementary therapies (2)


Letters to the Editor

Medication review

Pharmacists well placed to provide training

From Dr J. Krska, MRPharmS, and others

In the light of the recent concerns over whether there are benefits for patients in pharmacists providing medication review services, Petty et al (PJ, 21 May, p618) suggest that there are questions about who should perform reviews. Although we would agree there are no published randomised controlled trials of reviews performed by GPs or nurses, we would draw your readers’ attention to the extensive training programme we have undertaken in Angus Local Health Care Co-operative.

Following a pilot study in one practice in which five GPs and six nurses were trained to carry out reviews,1 all GPs and primary care nurses in the LHCC have been offered training. Initially 45 GPs took up this offer, which they perceived to be beneficial2 and others have since received the training. A total of 49 nurses have also received basic training in adding aspects of medication review to their routine practice.

Training enhanced the quality of GP reviews in the pilot practice1 and the outputs from GP reviews suggest that, given the same time and systematic approach used by clinical pharmacists, GP reviews are likely to be as effective as pharmacist reviews (data in preparation). The nurses’ reviews are still being evaluated, although we believe nurses are capable of identifying many common issues, addressing some themselves and referring onwards, most likely to pharmacists, for further advice.

Initial data suggest that more patients appear to prefer that a review be carried out by their GP than by a pharmacist.3 However, far from suggesting that pharmacists should abandon the concept of a medication review service, we believe our data support the idea that scarce pharmacist resource should be targeted to patients least likely to receive a review from a nurse or GP. This could include patients on large numbers of medicines, for whom a review will be time-consuming, and those in care homes or the housebound who are less likely to have a domiciliary review by a GP.

For the last year practices throughout the UK have been working towards targets set by the general medical services contract which includes a medication review, carried out by a doctor, nurse or pharmacist. Therefore it would seem appropriate to ensure that these other professionals receive some training in the process, so that all patients can benefit. Pharmacists are well placed to provide such training, as well as carrying out reviews themselves and perhaps supporting pharmacy technicians to contribute to review services in the future.

Janet Krska
David Gill
Angus LHCC

Denise Hansford
School of Pharmacy,
The Robert Gordon University, Aberdeen

References

1. Krska J, Ross SM, Watts M. Medication reviews provided by GPs and nurses: an evaluation of their quality. International Journal of Pharmacy Practice 2005;13:77–84.
2. Hansford D, Krska J, Gill D. General practitioners’ views of pharmacist-supported training in medication review. International Journal of Pharmacy Practice 2004;12(Suppl):R79.
3. Krska J, Ross SM. Medication review — whose job it is? International Journal of Pharmacy Practice 2002;10(Suppl):R86.

Send your letter to The Editor

Next Topic (Clinical trials)

Back to Top


©The Pharmaceutical Journal